A survey of >1400 Americans revealed that bladder control loss is more prevalent than most individuals realize. Although it is a common condition, 64% of those experiencing symptoms are currently not seeking treatment. The survey showed that diagnosis of bladder control loss improves knowledge, communication, and successful treatment of the condition. Furthermore, those diagnosed are more apt to successfully manage their condition, compared with those undiagnosed; are more likely to experience a sense of relief and that their quality of life has improved; and are comfortable talking about their condition with loved ones and/or health professionals. The survey also highlighted the following:
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs